3 not yet recruiting, 1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Lung Cancer (SCLC): new trials by email Literature Review of Lung Cancer (SCLC) trials Research Report on Lung Cancer (SCLC)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases Immunotherapy, Chemotherapy (Etoposide, Nab-paclitaxel, Irinotecan, or Lurbinectedin), low-dose radiation - Lung Cancer (SCLC) | Phase 2 | Not yet recruiting | Sichuan University | 30 | 2026-10-31 | 2026-05-05 |
| Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients No Intervention: Observational Cohort - Lung Cancer (NSCLC), Lung Cancer (SCLC) | Not yet recruiting | HAN GUANG | 160 | 2026-08-15 | 2026-08-03 | |
| PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor Lung Cancer (NSCLC), Lung Cancer (SCLC) | Not yet recruiting | Peking University Cancer Hospital & Institute | 40 | 2026-02-01 | 2026-03-05 | |
| Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the Lung Lung Cancer (NSCLC), Lung Cancer (SCLC) | Active not recruiting | The Christie NHS Foundation Trust | 80 | 2025-07-03 | 2025-10-01 |
Lung Neoplasms (4) · Carcinoma, Non-Small-Cell Lung (3) · Lung Diseases, Interstitial (1) · Melanoma (1) · Radiation Pneumonitis (1)
Lung Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Respiratory Tract Diseases (4) · Respiratory Tract Neoplasms (4) · Thoracic Neoplasms (4) · Bronchial Neoplasms (3) · Carcinoma, Bronchogenic (3) · Lung Diseases, Interstitial (1) · Lung Injury (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neuroectodermal Tumors (1) · Neuroendocrine Tumors (1)
130-nm albumin-bound paclitaxel (1) · Drug Therapy (1) · Etoposide (1) · Immunotherapy (1) · Irinotecan (1) · PM 01183 (1) · Radiation (1) · Radiosurgery (1)
HAN GUANG (1) · Peking University Cancer Hospital & Institute (1) · Sichuan University (1) · The Christie NHS Foundation Trust (1)
China (2) · United Kingdom (1)
You Lu (1)